ATE309196T1 - Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte - Google Patents

Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte

Info

Publication number
ATE309196T1
ATE309196T1 AT00917868T AT00917868T ATE309196T1 AT E309196 T1 ATE309196 T1 AT E309196T1 AT 00917868 T AT00917868 T AT 00917868T AT 00917868 T AT00917868 T AT 00917868T AT E309196 T1 ATE309196 T1 AT E309196T1
Authority
AT
Austria
Prior art keywords
arylpropylamines
aryloxy
producing
intermediate products
methylpyrrolidinone
Prior art date
Application number
AT00917868T
Other languages
English (en)
Inventor
Douglas Patton Kjell
Kurt Thomas Lorenz
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE309196T1 publication Critical patent/ATE309196T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Luminescent Compositions (AREA)
AT00917868T 1999-04-09 2000-03-22 Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte ATE309196T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12848099P 1999-04-09 1999-04-09
PCT/US2000/006423 WO2000061540A1 (en) 1999-04-09 2000-03-22 Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof

Publications (1)

Publication Number Publication Date
ATE309196T1 true ATE309196T1 (de) 2005-11-15

Family

ID=22435565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00917868T ATE309196T1 (de) 1999-04-09 2000-03-22 Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte

Country Status (10)

Country Link
US (1) US6541668B1 (de)
EP (1) EP1171417B1 (de)
JP (1) JP2002541235A (de)
AT (1) ATE309196T1 (de)
AU (1) AU3877500A (de)
CA (1) CA2362185C (de)
DE (1) DE60023870T2 (de)
DK (1) DK1171417T3 (de)
ES (1) ES2249256T3 (de)
WO (1) WO2000061540A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT414238B (de) 2001-03-06 2006-10-15 Lilly Co Eli Neues hydroxyliertes 3-phenoxy-3-phenyl-1- aminopropan und dieses aminopropan enthaltende pharmazeutische formulierung
US20040249170A1 (en) * 2002-01-24 2004-12-09 Alfio Borghese Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine
GB0229583D0 (en) * 2002-12-19 2003-01-22 Cipla Ltd A process for preparing duloxetine and intermediates for use therein
WO2005011583A2 (en) * 2003-07-28 2005-02-10 Leslie Joe Dunaway Treatment of allergic rhinitis and asthma
US20050197503A1 (en) * 2004-03-05 2005-09-08 Boehringer Ingelheim International Gmbh Process for the preparation of N-alkyl-N-methyl-3-hydroxy-3-(2-thienyl)-propylamines
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
WO2006004977A2 (en) * 2004-06-28 2006-01-12 Teva Pharmaceutical Fine Chemicals S.R.L. Process for the optical resolution and recycling of tomoxetine
WO2006020348A2 (en) * 2004-07-22 2006-02-23 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphs of atomoxetine hydrochloride
US7550605B2 (en) * 2004-08-05 2009-06-23 Sun Pharmaceutical Industries Ltd. Process for preparation of an anitdepressant compound
EP1794112A4 (de) * 2004-09-27 2009-11-04 Reddys Lab Ltd Dr Synthese von atomexetin-hydrochlorid
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
EP1856087A1 (de) * 2005-03-08 2007-11-21 Teva Pharmaceutical Industries Limited Kristallformen von (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamin-oxalat und deren herstellung
US7534900B2 (en) * 2005-03-14 2009-05-19 Teva Pharmaceutical Industries Ltd Process for the purification of duloxetine hydrochloride
EP1889828A1 (de) * 2005-04-05 2008-02-20 Teva Pharmaceutical Fine Chemicals S.R.L. Stabiles Atomoxetinhydrochlorid, Herstellungsverfahren und analytische Steuerung seiner Stabilität
JP2008501721A (ja) * 2005-04-05 2008-01-24 テバ ファーマシューティカル ファイン ケミカルズ ソチエタ レスポンサビリタ リミテ 安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節
US7485754B2 (en) * 2005-07-08 2009-02-03 Apotex Pharmachem Inc. Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers
CZ2005473A3 (cs) * 2005-07-21 2006-02-15 Zentiva, A. S Zpusob výroby hydrochloridu (R)-N-methyl-3-(2-methylfenoxy)-3-fenylpropylaminu (atomoxetinu)
US20080207923A1 (en) * 2005-09-22 2008-08-28 Santiago Ini Pure DNT-maleate and methods of preparation thereof
WO2007038253A2 (en) * 2005-09-22 2007-04-05 Teva Pharmaceutical Industries Ltd. Dnt-maleate and methods of preparation thereof
US20070281989A1 (en) * 2006-05-31 2007-12-06 Santiago Ini Process for preparing duloxetine and intermediates thereof
EP1863782A1 (de) 2005-12-05 2007-12-12 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamin)-3-(2-naphthol) thiophen, eine verunreinigung von duloxetin hydrochlorid
WO2007119114A2 (en) 2005-12-12 2007-10-25 Medichem, S.A. Improved synthesis and preparations of duloxetine salts
EP1798215A1 (de) * 2005-12-14 2007-06-20 SOLMAG S.p.A. Polymorph von Atomoxetin-hydrochloride in kristalliner Form
US7538232B2 (en) 2006-01-19 2009-05-26 Eli Lilly And Company Process for the asymmetric synthesis of duloxetine
MX2007011611A (es) * 2006-01-23 2007-10-18 Teva Pharma Fumarato de dnt y metodos de preparacion de ellos.
MX2007011727A (es) * 2006-01-23 2007-11-15 Teva Pharma Dnt-succinato y metodos de preparacion de el.
EP1976845A2 (de) * 2006-02-13 2008-10-08 Teva Pharmaceutical Industries Ltd Verfahren zur herstellung von (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)-propanamin, einem duloxetin-zwischenprodukt
EP1888554A2 (de) * 2006-02-21 2008-02-20 Teva Pharmaceutical Industries Ltd Verfahren zur herstellung von (s)-(-)-n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamin, einem duloxetin-zwischenprodukt
US20080146675A1 (en) * 2006-04-05 2008-06-19 Eugenio Castelli Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability
CN101448815A (zh) * 2006-05-23 2009-06-03 特瓦制药工业有限公司 度洛西汀hci多晶型物
CN100430370C (zh) * 2006-11-03 2008-11-05 华东理工大学 一种丙胺衍生物及其在制备托莫西汀中的应用
US20080145318A1 (en) * 2006-12-13 2008-06-19 Midha Kamal K Atomoxetine formulations and associated methods
EP2114912B1 (de) 2006-12-22 2012-04-04 Synthon B.V. Verfahren zur herstellung von duloxetin und verwandten verbindungen
EP2132192B1 (de) * 2007-03-05 2013-04-24 Lupin Limited Neues verfahren zur herstellung von duloxetinhydrochlorid
WO2009019719A2 (en) * 2007-08-09 2009-02-12 Ind-Swift Laboratories Limited Process for the preparation of 3-aryloxy-3-arylpropanamines
EP2060559A1 (de) 2007-11-19 2009-05-20 Cadila Pharmaceuticals Limited Herstellungsverfahren für enantiomerenreine 3-Hydroxy-3-Arylpropylamine und ihrer optischen Stereoisomere
US20100267968A1 (en) * 2007-12-26 2010-10-21 Orchid Chemicals & Pharmaceuticals Limited Method for the preparation of duloxetine hydrochloride
EP2240173A4 (de) * 2008-01-25 2013-07-17 Alphapharm Pty Ltd Pharmazeutische zusammensetzung von duloxetin mit verzögerter freisetzung
WO2009141833A2 (en) * 2008-04-17 2009-11-26 Ind-Swift Laboratories Limited An improved process for synthesizing highly pure atomoxetine
WO2010025238A2 (en) 2008-08-27 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
WO2010025287A2 (en) 2008-08-27 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
EP2558455B1 (de) 2010-04-13 2017-08-09 KRKA, D.D., Novo Mesto Synthese von duloxetin- und/oder pharmazeutisch akzeptablen salzen daraus
CN102863344B (zh) * 2012-07-20 2015-06-03 葫芦岛国帝药业有限责任公司 一种托莫西汀药物制备方法
CN106916074A (zh) * 2017-02-14 2017-07-04 万特制药(海南)有限公司 盐酸托莫西汀的制备
CN108929236A (zh) * 2017-05-26 2018-12-04 万特制药(海南)有限公司 盐酸托莫西汀的制备
CN110294680A (zh) * 2018-03-22 2019-10-01 北京深蓝海生物医药科技有限公司 一种盐酸阿托莫西汀的制备方法
CN111302958B (zh) * 2020-03-24 2023-05-02 合肥医工医药股份有限公司 一种光学纯的（r）-n-甲基-3-苯基-3-（邻-甲苯氧基）-丙胺盐酸盐制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75395B (de) 1980-11-14 1984-07-13 Lilly Co Eli
JPS6023656A (ja) 1983-07-20 1985-02-06 Nissan Motor Co Ltd 自動変速機の遊星歯車列
US4868344A (en) 1988-03-30 1989-09-19 Aldrich-Boranes, Inc. Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein
FI81083C (fi) * 1989-03-03 1990-09-10 Orion Yhtymae Oy Ett foerbaettrat foerfarande foer framstaellning av n-metyl-3-(p-trifluormetylfenoxi)-3-fenylpropylamin hydroklorid.
US5166437A (en) * 1989-03-03 1992-11-24 Orion-Yhtyma Oy Process for the preparation of fluoxetine
US5104899A (en) 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
US5362886A (en) * 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
ES2120368B1 (es) * 1996-06-14 1999-07-01 Almirall Prodesfarma Sa Procedimiento de obtencion de n-metil-3-(p-trifluorometilfenoxi)-3-fenilpropilamina y sus sales farmaceuticamente aceptables.
IT1283141B1 (it) * 1996-07-11 1998-04-07 Laporte Organics Francis S P A Procedimento per la preparazione di n-metil-3-(p-trifluorometilfenossi)-3-fenilpropilamina e dei suoi
TW514634B (en) 1997-10-14 2002-12-21 Lilly Co Eli Process to make chiral compounds

Also Published As

Publication number Publication date
CA2362185A1 (en) 2000-10-19
DE60023870T2 (de) 2006-06-14
EP1171417B1 (de) 2005-11-09
DK1171417T3 (da) 2006-02-20
WO2000061540A1 (en) 2000-10-19
US6541668B1 (en) 2003-04-01
EP1171417A1 (de) 2002-01-16
JP2002541235A (ja) 2002-12-03
ES2249256T3 (es) 2006-04-01
CA2362185C (en) 2009-06-02
AU3877500A (en) 2000-11-14
DE60023870D1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DE60023870T2 (de) Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte
DE69830336D1 (de) Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie
DE69942641D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE59906105D1 (de) Verfahren zur kontinuierlichen herstellung von 1,3-dioxolan-2-onen
DE69923906D1 (de) Verfahren zur Herstellung von Pyrazolo-(4,3-d)pyrimidin-7-ones und Zwischenprodukte davon
DE60017341D1 (de) Emulsion, und Verfahren zur Herstellung von Emulsionen und öligen Zusammensetzungen
DE60239842D1 (de) Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid
DE69928635D1 (de) Verfahren zur Herstellung von Produkten aus martensitischem rostfreiem Stahl
DE60002254T2 (de) Verfahren zur Herstellung von 4,6-diaminoresorcin
DE60222806D1 (de) Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DE10085452T1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE215525T1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
DE69922440D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 2,3-Pyridindicarboxylatderivaten
DE69821053D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidyl-Gruppen enthaltenden Polytriazinen
ATE339437T1 (de) 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
DE50205026D1 (de) Verfahren zur herstellung von n-substituierten 2,6-dialkylmorpholinen
DE19983485T1 (de) Verfahren zur Herstellung von Gasfedern
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE60004931D1 (de) Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron)
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
DE59802620D1 (de) Verfahren zur Herstellung von trans-(R,R)-Actinol
DE50005182D1 (de) Verfahren zur adiabatischen Herstellung von 3,4-Dichlornitrobenzol
DE69802329D1 (de) Verfahren zur Herstellung von 3,4 disubstituirten Dinitroanilinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1171417

Country of ref document: EP

REN Ceased due to non-payment of the annual fee